Trademark Overview
On Wednesday, March 13, 2019, a trademark application was filed for BINX CHECK with the United States Patent and Trademark Office. The USPTO has given the BINX CHECK trademark a serial number of 88338099. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Atlas Genetics Ltd.. The BINX CHECK trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical conditions screening kits composed of medical diagnostic reagents and assays for testing of bodily fluids for use in detection STD's and human papillomavirus and prostate-specific antigen, the aforementioned being for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental applications
Medical diagnostic kits for medical purposes consisting of medical specimen collection devices for testing the presence of biomarkers indicative of disease, medical conditions and levels of substances, namely, STDs, cancer genetic markers, fertility, and lifestyle concerns; Instrument and apparatus system for medical diagnostic use consisting of medical specimen collection devices, an electronic instrument, a disposable cartridge on which the test is performed in conjunction with the instrument and a range of medical devices used for sample collection to provide the test material, all sold to be used as a unit; the aforementioned systems are for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental application
Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring, and reporting services; medical diagnostic testing for biomarkers indicative of disease, STDs, cancer, genetic anomalies and disorders, fertility, and lifestyle issues, namely, collecting biological samples for in-home testing for medical purposes, providing testing and diagnostic services thereto for medical purposes, and medical information services, namely, reporting test results to customers test kits
